Clinical Trial Update: Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a biological therapy for high-risk patients or those with EBV-induced lymphomas and EBV-associated malignancies; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv-associated Malignancies
• Ebv-induced Lymphomas
• Transplant Patients with Ebv Viremia At High Risk of Developing Recurrent Ebv Lymphoma

Drugs mentioned

• Atara Biotherapeutics biological therapy

Snippet

Sponsor: Atara Biotherapeutics | Conditions: EBV-induced Lymphomas, EBV-associated Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-13